188 related articles for article (PubMed ID: 26885008)
41. [Tumor markers. Personal experience--screening of breast cancer by determining CEA in nipple discharge].
Inaji H; Koyama H
Gan To Kagaku Ryoho; 1991 Feb; 18(2):313-7. PubMed ID: 1992927
[TBL] [Abstract][Full Text] [Related]
42. [Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].
Chen Y; Zheng YH; Lin YY; Hu MH; Chen YS
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):842-6. PubMed ID: 22335950
[TBL] [Abstract][Full Text] [Related]
43. Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings.
Sauter ER; Wagner-Mann C; Ehya H; Klein-Szanto A
Cancer Detect Prev; 2007; 31(1):50-8. PubMed ID: 17317033
[TBL] [Abstract][Full Text] [Related]
44. ErbB-2 protein levels in nipple discharge: role in diagnosis of early breast cancer.
Inaji H; Koyama H; Motomura K; Noguchi S; Mori Y; Kimura Y; Sugano K; Ohkura H
Tumour Biol; 1993; 14(5):271-8. PubMed ID: 7901888
[TBL] [Abstract][Full Text] [Related]
45. Is a one-step operation for breast cancer patients presenting nipple discharge without palpable mass feasible?
Hou MF; Tsai KB; Ou-Yang F; Lin HJ; Liu CS; Chai CY; Huang TJ; Liu GC
Breast; 2002 Oct; 11(5):402-7. PubMed ID: 14965703
[TBL] [Abstract][Full Text] [Related]
46. The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients.
Yu S; Zhao J; Wang M; Cheng G; Li W; Tang L; Yao S; Pang L; Yin X; Jing Y; Cheng H
Front Med (Lausanne); 2022; 9():945433. PubMed ID: 36091709
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of combined testing of YKL-40 with CEA in Chinese colorectal cancer patients.
Ye HM; Lu YZ; Liang XM; Lin YZ; Li Y; Zhang ZY; Tzeng CM
Clin Lab; 2014; 60(3):397-405. PubMed ID: 24697115
[TBL] [Abstract][Full Text] [Related]
48. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
[TBL] [Abstract][Full Text] [Related]
49. Retrospective analysis of glycan-related biomarkers based on clinical laboratory data in two medical centers during the past 6 years.
Zhang M; Dou H; Yang D; Shan M; Li X; Hao C; Zhang Y; Zeng P; He Y; Liu Y; Fu J; Wang W; Hu M; Li H; Tian Q; Lei S; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():141-163. PubMed ID: 30905446
[TBL] [Abstract][Full Text] [Related]
50. CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma.
Liu P; Zhu Y; Liu L
Int J Clin Exp Pathol; 2015; 8(11):15112-7. PubMed ID: 26823852
[TBL] [Abstract][Full Text] [Related]
51. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.
Zhao Y; Verselis SJ; Klar N; Sadowsky NL; Kaelin CM; Smith B; Foretova L; Li FP
J Clin Oncol; 2001 Mar; 19(5):1462-7. PubMed ID: 11230492
[TBL] [Abstract][Full Text] [Related]
52. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].
Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890
[TBL] [Abstract][Full Text] [Related]
53. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
Eskelinen M; Kataja V; Hämäläinen E; Kosma VM; Penttilä I; Alhava E
Anticancer Res; 1997; 17(2B):1231-4. PubMed ID: 9137478
[TBL] [Abstract][Full Text] [Related]
54. Changing patterns of Serum CEA and CA199 for Evaluating the Response to First-line Chemotherapy in Patients with Advanced Gastric Adenocarcinoma.
He B; Zhang HQ; Xiong SP; Lu S; Wan YY; Song RF
Asian Pac J Cancer Prev; 2015; 16(8):3111-6. PubMed ID: 25921105
[TBL] [Abstract][Full Text] [Related]
55. The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer.
Li F; Guo Y; Liu J; Zhang R
PLoS One; 2017; 12(5):e0178427. PubMed ID: 28562634
[TBL] [Abstract][Full Text] [Related]
56. Implications of nipple discharge in Hong Kong Chinese women.
Kan WM; Chen C; Kwong A
Hong Kong Med J; 2018 Feb; 24(1):18-24. PubMed ID: 29302019
[TBL] [Abstract][Full Text] [Related]
57. Indicators of breast cancer in patients undergoing microdochectomy for a pathological nipple discharge in a middle-income country.
Lesetedi C; Rayne S; Kruger D; Benn CA
J Surg Res; 2017 Dec; 220():336-340. PubMed ID: 29180200
[TBL] [Abstract][Full Text] [Related]
58. The Clinical Value of the Combined Detection of Enhanced CT, MRI, CEA, and CA199 in the Diagnosis of Rectal Cancer.
Hao C; Sui Y; Li J; Shi Y; Zou Z
J Oncol; 2021; 2021():8585371. PubMed ID: 34335762
[TBL] [Abstract][Full Text] [Related]
59. Retrospective analysis of pathologic nipple discharge.
Yang L; Wu D; Fan ZM
Genet Mol Res; 2015 Feb; 14(1):1443-9. PubMed ID: 25730083
[TBL] [Abstract][Full Text] [Related]
60. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge.
Cabioglu N; Hunt KK; Singletary SE; Stephens TW; Marcy S; Meric F; Ross MI; Babiera GV; Ames FC; Kuerer HM
J Am Coll Surg; 2003 Mar; 196(3):354-64. PubMed ID: 12648684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
